Check-Cap Ltd. - התחייבויות לטווח ארוך של החברה CHEK

Check-Cap Ltd. (CHEK) develops innovative video capsules for X-ray bowel examinations without prior cleansing, which simplifies the detection of oncology. The asset value tracked on the GURU.Markets chart currently stands at 0.00. Demand for such tests is independent of economic cycles or seasonality. Despite its Israeli origin and logistical challenges, the business minimizes risks through US patents.

For Check-Cap Ltd. (CHEK), which is developing non-invasive colorectal cancer diagnostics, the company's level of long-term debt reflects the volume of capital raised for years ahead to commercialize X-ray systems. This metric aggregates all liabilities with maturities exceeding twelve months, allowing investors to assess the issuer's debt load and financial stability during the period of zero operating revenue.